The present invention provides methods, compounds, pharmaceutical compositions, and kits for the augmentation of erythropoiesis by potentiating erythropoietin-induced differentiation with angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II analogues, AII fragments or analogues thereof or AII AT.sub.2 type 2 receptor agonists as a therapeutic adjunct. The method is useful for the treatment of congenital or acquired aplastic or hypoplastic anemia associated with chronic renal failure, end-stage renal disease, renal transplantation, cancer, AIDS, chemotherapy, radiotherapy, bone marrow transplantation and chronic diseases.

 
Web www.patentalert.com

< Peptides for detection of antibody to Ehrlichia ewingii

< Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation

> Method and apparatus for establishing multiple bandwidth-limited connections for a communication device

> System and method for changing order priority levels in an electronic trading environment

~ 00620